Skip to main content
  •  
  • NRG Apps
  • News
  • Login
NRG Oncology
  • Patients
    • Patients Overview
    • Patient Study Materials
    • Patient Advocate Committee
  • Our Research
    • red icon of a clipboard with a medical + on it Clinical Trials
    • red icon of a book Research Resources
      • Research Resources Overview
      • Ancillary Projects & Data Sharing
      • Biospecimen Access
      • Data Management Resources
      • DMC Charters and Minutes
      • Investigator Resources
      • Quality Assurance (QA) Resources
      • Statistical Reports
    • red icon of a person reading a book or magazine Publications & Presentation Resources
  • Committees
    • Leadership & Committee Openings
    • red icon of a book Oversight Committees
      • Oversight Committees Overview
      • Data Monitoring Committee
      • Early Phase Trial Oversight Committee
      • Executive Committee
      • Protocol Operations Management
      • Research Strategy
    • Disease Specific Committees
      • Disease Specific Committees Overview
      • Brain Tumor
      • Breast Cancer
      • Gastrointestinal Cancer
      • Genitourinary Cancer
      • Gynecologic Cancer
        • Gynecologic Cancer Overview
        • Cervix/Vulva Cancer Subcommittee
        • Ovarian Cancer Subcommittee
        • Rare Tumor Subcommittee
        • Uterine Corpus Cancer Subcommittee
      • Head and Neck Cancer
      • Lung Cancer
    • red icon of a person reading a book or magazine NCORP Committees
      • NCORP Committees Overview
      • Cancer Care Delivery Research
      • Cancer Prevention & Control
      • Health Care Access
      • Patient Centered Outcomes Research
    • red icon of a person reading a book or magazine Non-Disease Specific Committees
      • Non-Disease Specific Committees Overview
      • Cancer Care Delivery Research
      • Cancer Prevention & Control
      • Developmental Therapeutics (DT)
        • Developmental Therapeutics (DT) Overview
        • DT Radiation Therapy Subcommittee
        • DT Gynecologic Phase I Subcommittee
        • Sarcoma Subcommittee
      • Patient Centered Outcomes Research
      • Translational Science
    • Scientific Core Committees
      • Scientific Core Committees Overview
      • Health Care Access (HCA)
        • Health Care Access (HCA) Overview
        • HCA Committee Events & Announcements
      • Imaging
        • Imaging Overview
        • Theranostics Subcommittee
      • Medical Oncology
        • Medical Oncology Overview
        • Immunotherapy Subcommittee
        • Pharmacy Subcommittee
      • Pathology
      • Protocol Support
        • Protocol Support Overview
        • CRA Subcommittee
        • CTN Subcommittee
        • Education & Training Subcommittee
        • Mentorship Subcommittee
        • Protocol Review Subcommittee
        • Quality Control & Communication Subcommittee
      • Radiation Oncology
        • Radiation Oncology Overview
        • Medical Physics Subcommittee
        • Theranostics Subcommittee
      • Surgical Oncology
    • Administrative Committees
      • Administrative Committees Overview
      • Ancillary Projects
      • Communications
      • Investigator & Career Development
        • Investigator & Career Development Overview
        • Early Career Mentorship Subcommittee
        • Investigator Development Subcommittee
      • Membership
        • Membership Overview
        • Canadian Members Subcommittee
        • International Members Subcommittee
        • Veteran Affairs/Military Treatment Facility Subcommittee
      • Patient Advocate Committee
      • Publications
  • About Us
    • red icon of a clipboard with a medical + on it What is NRG Oncology
      • What is NRG Oncology Overview
      • Scientific Focus
      • Legacy Groups
      • Support NRG
      • Contact Us
    • red icon of a book Policies and Bylaws
    • Organizational Overview
      • Organizational Overview
      • Organizational Structure
      • Operations
      • SDMC
      • NCORP (Overview & PIs)
      • Biospecimen Bank
      • Translational Science
      • CIRO
    • Membership
      • Membership Overview
      • Member Information Form
      • Membership Requirements
      • Membership Applications & Roster Forms
      • Membership Committee Reviews
      • Member Institution Lists
    • Education & Training
      • Education & Training Overview
      • CLASS Learning Modules
      • Credentialing & Other Resources
      • VisionTree Training
    • red icon of a person reading a book or magazine Mentorship Programs
      • Mentorship Programs Overview
      • Health Care Access Fellowship
      • Early Career Mentored Fellowship Program
      • Clinical Research Coordinator Mentor Program
    • red icon of a book Media & News
      • Media & News Overview
      • Newsletters
      • The NRG Oncology Podcast
      • Weekly Broadcasts
  • Meetings
    • Meetings Overview
    • NRG Oncology 2026 Winter Meeting
    • Past NRG Meetings (past two years)
    • Future NRG Meetings
    • NRG Meeting Attendee Policies
    • Major Scientific Meetings
Login
NRG Apps
Admin Portal
News
  • NRG Apps
  • News
  • Login
NRG Oncology
  • Patients

    • Patients Overview
    • Patient Study Materials
    • Patient Advocate Committee
  • Our Research

    Our Research

    See our clinical trial portfolio as well as other areas of research conducted by NRG and our publication process.

    Our Research Overview
    • red icon of a clipboard with a medical + on it Clinical Trials
    • red icon of a book Research Resources
    • red icon of a person reading a book or magazine Publications & Presentation Resources
    woman sitting at a desk, hands on keyboard. there is a man behind her, also at a desk. there is are large windows behind them

    The NRG Summer 2025 Semiannual Meeting will be held in person at the Marriott Marquis Hotel in Washington, D.C., from July 24, 2025 – July 26, 2025.

    Explore Resources
    two men sitting and talking, one appears to be a doctor, in a lab coat. the doctor has his hand on the man's shoulder

    Search through all available NRG Oncology protocols and available materials.

    Find Trials
    • Research Resources Overview

      A compilation of all resources relevant to research conduct or reporting.

    • Ancillary Projects & Data Sharing

      Resources, contact information, applications, and review cycles for ancillary projects and data sharing.

    • Biospecimen Access

      How to request biospecimens collected from patients enrolled on NRG trials (and legacy groups GOG, NSABP, and RTOG).

    • Data Management Resources

      Data Management contact list, compiled resources for sites, and PRO resources.

    • DMC Charters and Minutes

      Data Monitoring Committee (DMC) Panels A, B, and C minutes are password protected (CTEP IAM/ID.me login).

    • Investigator Resources

      Investigator-specific resources or tools to aid in clinical trial participation or conduct.

    • Quality Assurance (QA) Resources

      Information and additional links to resources for NRG’s audit program.

    • Statistical Reports

      NRG trial statistical reports shared at NRG Semiannual Meetings.

    room with rows of chairs, filled with people. there is a speaker at the front on a stage

    Are you presenting on behalf of NRG Oncology? We have templates for presentations and posters for our research here.

    Find a Template
  • Committees

    Committees

    Our committees are a network of professionals with varying experience that come together to advance NRG’s research.

    Committees Overview
    • Leadership & Committee Openings
    • red icon of a book Oversight Committees
    • Disease Specific Committees
    • red icon of a person reading a book or magazine NCORP Committees
    • red icon of a person reading a book or magazine Non-Disease Specific Committees
    • Scientific Core Committees
    • Administrative Committees

    NRG Oncology is comprised of several committees and subcommittees that conduct or support NRG trials.

    Find a Committee
    Man standing at a podium and another man is next to him at a table, talking into a mic

    Check and apply to open membership or leadership positions within our organization.

    Check Openings
    • Oversight Committees Overview

      Committees charged with guiding, reviewing, evaluating, and implementing clinical trials in alignment with the NCTN.

    • Data Monitoring Committee

      Reviews the efficacy and morbidity data of trials to ensure decisions regarding these studies are ethically responsible.

    • Early Phase Trial Oversight Committee

      Oversees the group’s Phase I and non-randomized Phase II trials for safety and lead-in components of protocols.

    • Executive Committee

      Comprised of NRG leadership roles and tasked with setting priorities for the group.

    • Protocol Operations Management

      Monitors the progress of activated studies and assesses trial accrual as well as other trial performance metrics.

    • Research Strategy

      Focused on study development and providing feedback or recommendations to disease site and scientific core committees.

    • Disease Specific Committees Overview

      Comprised of 7 committees dedicated to the disease sites most commonly represented in NRG research.

    • Brain Tumor

      Focused on brain tumor research including primary and secondary tumors of the central nervous system.

    • Breast Cancer

      Focused on research aimed at improving the management and outcomes of breast cancer.

    • Gastrointestinal Cancer

      Comprised of colorectal and non-colorectal cancer sectors focused on reducing the burden of GI malignancies for patients.

    • Genitourinary Cancer

      Focused on improving outcomes in GU cancers including prostate, kidney. Bladder, & testicular cancers.

    • Gynecologic Cancer

      Oversees all gynecologic subcommittee cancer research efforts including clinical trial design and translational research.

    • Head and Neck Cancer

      Focused on research aimed at improving the management and outcomes of head & neck cancer.

    • Lung Cancer

      Focused on improving survival and quality of life for patients with non-metastatic lung cancer.

    • NCORP Committees Overview

      NRG NCORP includes committees that improve delivery, disease prevention & control, access & patient quality-of-life.

    • Cancer Care Delivery Research

      Improves clinical outcomes & patient well-being by minimizing factors that may influence care delivery.

    • Cancer Prevention & Control

      Prioritizes interventional studies to improve symptom burden or prevent cancer morbidity.

    • Health Care Access

      Assesses & eliminates differences in health care access to improve cancer care and outcomes.

    • Patient Centered Outcomes Research

      Assesses patient-reported outcomes in therapeutic and cancer control trials.

    • Non-Disease Specific Committees Overview

      Consists of four committees that conduct NRG trials and support research within the disease site committees.

    • Cancer Care Delivery Research

      Improves clinical outcomes & patient well-being by minimizing factors that may influence care delivery.

    • Cancer Prevention & Control

      Prioritizes interventional studies to improve symptom burden or prevent cancer morbidity.

    • Developmental Therapeutics (DT)

      Identifies dose, schedule & preliminary efficacy of novel therapeutic approaches on Phase I & II trials.

    • Patient Centered Outcomes Research

      Assesses patient-reported outcomes in therapeutic and cancer control trials.

    • Translational Science

      Provides translational science expertise to NRG trials & education on new technologies.

    • Scientific Core Committees Overview

      Consists of seven committees that serve as shared resources of expertise and technology for conducting our trials.

    • Health Care Access (HCA)

      Assesses & eliminates differences in health care access to improve cancer care and outcomes.

    • Imaging

      Charged with enhancing the use of imaging on NRG trials and evaluating new novel imaging for trials.

    • Medical Oncology

      Supports systemic treatments used in NRG trials.

    • Pathology

      Assists with the pathology components across disease sites on NRG trials.

    • Protocol Support

      Responsible for overseeing support and quality control of protocol-related activities.

    • Radiation Oncology

      Coordinates NRG’s radiation oncology-related activities for trials.

    • Surgical Oncology

      Focused on providing expertise on NRG trials that require surgical components in treatment.

    • Administrative Committees Overview

      Committees that manage efforts to build engagement, reach, & result reporting for clinical trials & information.

    • Ancillary Projects

      Responsible for the review & conduct of ancillary projects utilizing NRG data.

    • Communications

      Responsible for developing and disseminating content to members & the public regarding NRG trials & efforts.

    • Investigator & Career Development

      Focused on fostering investigator growth and engagement in NRG.

    • Membership

      Responsible for maintaining the process for which NRG members are accepted & operating within the group.

    • Patient Advocate Committee

      Advocates (patients/ caregivers) who partner with our researchers and liaison to their communities regarding research.

    • Publications

      Focused on releasing NRG results in a timely manner via journal publications, presentations, & more.

    • Gynecologic Cancer Overview

      Oversees all gynecologic subcommittee cancer research efforts including clinical trial design and translational research.

    • Cervix/Vulva Cancer Subcommittee

      Part of the GYN cancer committee umbrella. Focused on research pertaining to the cervix or vulva.

    • Ovarian Cancer Subcommittee

      Part of the GYN cancer committee umbrella. Focused on research pertaining to the ovaries.

    • Rare Tumor Subcommittee

      Part of the GYN cancer committee umbrella. Focused on rare cancer types & their biomolecular/genetic abnormalities.

    • Uterine Corpus Cancer Subcommittee

      Part of the GYN cancer committee umbrella. Focused on research pertaining to uterine malignancies.

    • Developmental Therapeutics (DT) Overview

      Identifies dose, schedule & preliminary efficacy of novel therapeutic approaches on Phase I & II trials.

    • DT Radiation Therapy Subcommittee

      Focuses on safety and efficacy of radiotherapy treatments in Phase I & II trials.

    • DT Gynecologic Phase I Subcommittee

      Focuses on safety and efficacy of therapeutics specific to Phase I gynecologic cancers.

    • Sarcoma Subcommittee

      Focuses on research pertaining to or correlating with sarcoma cancers.

    • Health Care Access (HCA) Overview

      Assesses & eliminates differences in health care access to improve cancer care and outcomes.

    • HCA Committee Events & Announcements

      HCA has several events, workshops, symposia & more to with varying topics and learning opportunities.

    • Imaging Overview

      Charged with enhancing the use of imaging on NRG trials and evaluating new novel imaging for trials.

    • Theranostics Subcommittee

      A collaboration of the Imaging & Radiation Oncology Committees for trials that include theranostics.

    • Medical Oncology Overview

      Supports systemic treatments used in NRG trials.

    • Immunotherapy Subcommittee

      Evaluates NRG concepts that utilize immunotherapy.

    • Pharmacy Subcommittee

      Supports NRG trials with pharmacy-specific input including drug information & toxicity management.

    • Protocol Support Overview

      Responsible for overseeing support and quality control of protocol-related activities.

    • CRA Subcommittee

      Advisory subcommittee helping facilitate the goals of the PSC specific to clinical research associates.

    • CTN Subcommittee

      Advisory subcommittee helping facilitate the goals of the PSC specific to clinical trial nurses.

    • Education & Training Subcommittee

      Develops educational programs for CRAs and CTNs in attendance at the NRG Meetings.

    • Mentorship Subcommittee

      Develops and refunds that CRA/CTN Mentorship Program.

    • Protocol Review Subcommittee

      Prospectively reviews protocols & major amendments for barriers & compliance.

    • Quality Control & Communication Subcommittee

      Identifies common audit issues, resolves data issues & distributes content through NRG Communications.

    • Radiation Oncology Overview

      Coordinates NRG’s radiation oncology-related activities for trials.

    • Medical Physics Subcommittee

      Composed of physicists with expertise in the development of technology employed in radiation therapy.

    • Theranostics Subcommittee

      A collaboration of the Imaging & Radiation Oncology Committees for trials that include theranostics.

    • Investigator & Career Development Overview

      Focused on fostering investigator growth and engagement in NRG.

    • Early Career Mentorship Subcommittee

      Committed to the inclusion of early-career investigators through the protocol development process.

    • Investigator Development Subcommittee

      Focused on expanding opportunities & engagement for investigators at all career levels.

    • Membership Overview

      Responsible for maintaining the process for which NRG members are accepted & operating within the group.

    • Canadian Members Subcommittee

      Focused specifically on the accrual & research aims for Canadian sites.

    • International Members Subcommittee

      Focused on accrual & research aims for international institutions.

    • Veteran Affairs/Military Treatment Facility Subcommittee

      Addresses research aims & obstacles specific to veteran and military treatment facilities.

  • About Us

    About Us

    NRG conducts multi-institutional phase II & III clinical trials as well as phase I & translational biological studies.

    About Us Overview
    • red icon of a clipboard with a medical + on it What is NRG Oncology
    • red icon of a book Policies and Bylaws
    • Organizational Overview
    • Membership
    • Education & Training
    • red icon of a person reading a book or magazine Mentorship Programs
    • red icon of a book Media & News
    woman standing at a mic with rows of tables next to and behind her with people sitting at them

    Make your voice heard. Join NRG and help us move the needle in cancer research.

    Register Here
    • What is NRG Oncology Overview

      Learn more about who we are and what our overarching organizational goals are as an NCI NCTN group.

    • Scientific Focus

      NRG has several scientific aims through our research. Learn more in our scientific focus section.

    • Legacy Groups

      NRG is comprised of three legacy groups. Learn more about our history & the three Foundations.

    • Support NRG

      Learn how you can be a part of our mission to improve outcomes for all impacted by cancer.

    • Contact Us

      Fill out our contact form or find specific contact information by department.

    Policies, guidelines, bylaws, and charters pertaining to our organization & research.

    View All
    • Organizational Overview

      This overview leads into the many sections and centers that work together under NRG to improve cancer outcomes.

    • Organizational Structure

      See the organizational charts the outline the multiple sections that keep NRG research moving forward.

    • Operations

      These offices help streamline the administrative and protocol development areas of our trials from start to finish.

    • SDMC

      The Statistics and Data Management Center provide expertise for design, conduct, and analysis of NRG trials.

    • NCORP (Overview & PIs)

      NRG’s NCI Community Oncology Research Program brings cancer trials to the community.

    • Biospecimen Bank

      NRG has Biospecimen Banks located in Columbus, Pittsburgh, Houston, and San Francisco. Learn more here.

    • Translational Science

      NRG’s translational science program intersects with all NRG clinical trial as well as ancillary projects.

    • CIRO

      The Center for Innovation in Radiation Oncology houses contouring atlases, templates, & tools to conduct research.

    • Membership Overview

      Includes Membership information, related documents or forms, requirements, and other applicable items.

    • Member Information Form

      All members are required to participate in our membership database form even if the response is opting out.

    • Membership Requirements

      Outline of membership categories including associated requirements & responsibilities.

    • Membership Applications & Roster Forms

      Information on how to apply for membership, make changes to your roster & who to contact for questions.

    • Membership Committee Reviews

      This password-protected area includes the content reviewed during Membership Committee meetings twice a year.

    • Member Institution Lists

      All available lists of member sites by type of member, location, CTEP ID, & voting members.

    • Education & Training Overview

      NRG offers educational materials and training courses for a variety of topics relevant to the conduct of our research.

    • CLASS Learning Modules

      Compliance, Learning, and SOP Solutions (CLASS) platform is a learning management system supported by CTSU.

    • Credentialing & Other Resources

      Contact information for RT & Imaging credentialing plus links to other important credentialing or trial resources.

    • VisionTree Training

      VisionTree platform, used on some NRG trials, hosts an NRG-VisionTree training webinar once a month.

    • Mentorship Programs Overview

      NRG is committed to the future of cancer research in all areas and levels of expertise through our mentorship programs.

    • Health Care Access Fellowship

      Health Care Access Fellowship

    • Early Career Mentored Fellowship Program

      NRG selects early-stage investigators via application process to be part of a mentored experience in trial development.

    • Clinical Research Coordinator Mentor Program

      Learn more about our CRC mentorship program and how to become a mentor or mentee.

    • Media & News Overview

      NRG has multiple sources of news including podcasts, newsletters, email broadcasts, and more.

    • Newsletters

      Archive of all NRG Currents newsletter editions. Each edition discusses a wide range of topics.

    • The NRG Oncology Podcast

      The NRG Oncology Podcast is an ongoing streaming podcast with new episodes each month.

    • Weekly Broadcasts

      NRG releases a weekly broadcast each Monday with all important updates on studies and other news.

  • Meetings

    • Meetings Overview
    • NRG Oncology 2026 Winter Meeting
    • Past NRG Meetings (past two years)
    • Future NRG Meetings
    • NRG Meeting Attendee Policies
    • Major Scientific Meetings

NRG Oncology PSC 2025 Winter Meeting Wrap Up

02/18/2025

Written by: Erin McCaig RN, BSN from Cancer Research for the Ozarks

On behalf of the Protocol Support Committee (PSC), we would like to thank everyone who attended the NRG Oncology Semiannual Meeting in balmy Phoenix. There were 134 in-person attendees and 187 virtual attendees at the PSC Nurse/CRA Introduction to Clinical Trials: Principles of Clinical Trial Management Thursday morning. There were 72 in-person attendees and 122 virtual attendees at the afternoon Introductions to Clinical Trials Discussion Sessions. Our Friday morning PSC Continuing Education Sessions saw 108 in-person attendees and 166 virtual attendees.

A huge thank you is owed to NRG Oncology for their commitment to offering a virtual option for our continuing education sessions. And a huge congratulations are owed to our wonderful Education & Training Subcommittee led by Chair, Cindy Licavoli, along with Vice Chairs Marissa Weiss, and Jacqueline Ludwig, as well as our NRG Oncology liaison, Kristen Kotsko, for putting on two days of fabulous programming.

Thursday morning’s education session got off to a great start with a warm welcome from Sharon Hartson Stine, NRG Oncology Executive Director. Sharon provided an overview of NRG Oncology’s inception and current operational status. Karan Boparai highlighted NRG Oncology Membership and thanked attendees for their contribution for NRG’s continued success. Judy Langer walked us through the history of our federal regulations and the impact regulatory affairs has on our work today. Judy started in biblical times which left me wondering if other cultural and/or religious practices have ancient documentation of randomized clinical trials?

Next up, Sara McCartney discussed Expedited Adverse Event Reporting, including changes to 24-hour reporting for all SAE’s and reviewed the new streamlined guidelines for SAE reporting. Erica Gray’s pre-corded presentation reminded us that our paper DARF’s expire this month and new DARF’s are currently available on the PMB website. Joseph Mroziak provided much appreciated information on RAVE training and Mary Jo Antonelli educated us all on NRG Quality Assurance Audit readiness. Lisa Beaverson reminded us of the importance of biospecimen collection and even more importantly, to use unexpired collections kits and blood tubes when collecting research samples. Dr. Shannon Puhalla presented RECIST criteria, a crowd favorite. The takeaway message is to collaborate with your radiologist and investigator to ensure reproducible lesions are followed and to record no more than 2 lesions per organ. Nancy Fusco highlighted our Mentorship program and thanked our wonderful Mentors for the incredible work they do each day. She also reminded attendees that resources are available on the NRG Oncology website. Kandie Dempsey closed out our morning with a quick update on Patient Reported Outcome Compliance.

The Thursday afternoon Discussion sessions were highly attended and covered a variety of topics, including Patient Screening & Enrollment; Treatment Modalities in Clinical Trial Management; Data Management; and a crowd favorite, Adverse Event Reporting. There was thoughtful discussion and enthusiastic participation by many! Thank you to the many PSC members who participated in topic presentations and meeting coordination: Cindy Licavoli, Erin McCaig, Tiffany Elsea, Terry Thomas, Pamela Mason, Alison Ivey, Alex Kudryashev, Mark Fischer, Rachel Lacy, Cortney Montgomery, Stacey Lewis, and Brittany Lansford. A huge THANKS is owed to Jackie Ludwig, our IT expert, who ran our virtual sessions, monitored the chat, and kept us organized and on time throughout the afternoon, despite internet connection issues.

Friday’s PSC Continuing Education Session, facilitated by Jackie Ludwig, with assistance from Alison Ivey, started with a Mentorship & Colleague Retention panel presentation by Edward Bleta, Pamela Mason and Erik Harden. These three reminded us that praise, recognition, and appreciation for one another often goes further than financial compensation. I hope you all take a few minutes to recognize a co-worker after reading this article. Dr. Thomas George followed our panel discussion with a presentation on Early Onset Colorectal Cancer & the Microbiome. How many of you texted your energy drinking friends and family members after that one? Wow! What an excellent, thought-provoking presentation. Next, we heard a pre-recorded presentation from pharmacist, Kayla Dye. Kayla reviewed PMB and Aurora Updates. Hopefully most every site has used Aurora by now. Speaking from personal experience, Aurora is a colorful and intuitive website! Following a short break, Dr. Shannon Jones McCall presented Pathology 101. I learned so much from Dr. McCall’s presentation. Research is often a silo approach with so many experts scattered throughout a campus or healthcare system. It is challenging to say the least, but Dr. McCall reminded me how important each piece is to the clinical trial continuum. It isn’t merely checking off the to-do list that the FFPE or slides were sent, it is ensuring that the patient and care team understand that this may be the only tissue left for future decisions to be made. Ultimately, it is on all of us to work together to help the patient make the best decision for themselves with the most up to date information available. Our morning came to close with an emotional and thoughtful panel presentation: Onboarding New CRP’s by Tiffany Elsea and Stacey Lewis. I was reminded of my “why” and left the meeting feeling renewed in my mission to serve and passion for oncology research.

Thank you to everyone who participated by presenting, facilitating, and asking questions. So much valuable information was presented! You can find pdfs of the slide presentations and recordings for all PSC sessions at this link (login required):

Protocol Support Committee Materials

We are excited to report the Protocol Support Committee obtained approval for a total of 11.25 continuing education contact hours through the Virginia Nursing Association for our Winter 2025 PSC programing. A reminder to complete the evaluations, certificates will be emailed on 2/18/2025. For any questions, contact balld@nrgoncology.org

Mark your calendars for our next NRG Oncology Semiannual meeting July 24-26, 2025, in Washington, DC. Please feel free to share your thoughts and ideas about topics of interest for future meetings by emailing us at NRG-PSC@nrgoncology.org. Your input and participation are always encouraged and welcomed!

Don’t forget: If you are interested in participating in our innovative Mentorship program, as either a mentor or mentee, we encourage you to visit our website at the following link: Introductory Materials or email directly: pscmentorship@NRGOncology.org. This program works to provide resources, support, and guidance for research nurses and CRAs. Also, if you are interested in being a member of one of the PSC subcommittees watch for the election process in September.

Back

News

Home All News
  • NRG Newsletters
    • 2024 Newsletters
    • 2023 Newsletters
  • Weekly Broadcasts
    • 2024 Weekly Broadcast Archive
    • 2025 Weekly Broadcast Archive

Stay current with science. Sign up for our newsletter.

grey diamond icon

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

  • $25
  • $50
  • $75
  • $100
  • Other

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.

NRG logo
Four Penn Center,
1600 JFK Blvd, Suite 1020,
Philadelphia, PA 19103

Phone: 267-519-6630

Fax: 215-854-0716

Email:
info@nrgoncology.org

Quick Links

  • News
  • NRG Oncology Meetings
  • Our Research
  • Support Our Mission

Membership

  • Membership Requirements
  • Membership Applications & Roster Forms
  • Member Institution Lists

Resources

  • Clinical Trial Search
  • The NRG Oncology Podcast
  • Presentation Templates & Slides
  • Policies & Bylaws
  • Education & Training

For Patients

  • Patient Study Materials
  • The NRG Oncology Patient Advocate Committee

About Us

  • Who We Are & What We Do
  • Statisics and Data Management Center (SDMC)
  • Biospecimen Banks
  • Center for Innovation in Radiation Oncology (CIRO)
  • NRG NCORP Research Base

© 2025 NRG Oncology